Enoxaparin Becat Laboratorios Farmacéuticos Rovi

Enoxaparin Sodium is an anticoagulant medication used to prevent and treat blood clots. It is commonly administered via subcutaneous or intravenous routes, including during haemodialysis.

Enoxaparin Sodium is primarily used to prevent and treat deep vein thrombosis (DVT) and pulmonary embolism (PE). It is also used to prevent blood clots in patients undergoing certain medical procedures or those who are immobile. This medication is often administered via subcutaneous injection or intravenous infusion, including during haemodialysis.

Common effects of Enoxaparin Sodium may include bruising, bleeding, and pain at the injection site. Some individuals may experience allergic reactions or unusual bleeding. It is important to monitor for signs of excessive bleeding while using this medication.

Enoxaparin Sodium should be used with caution in patients with a history of bleeding disorders or those who are at high risk for bleeding. It is important to follow the prescribed dosage and administration instructions carefully. Patients should inform their healthcare provider about any other medications they are taking to avoid potential interactions.

Enoxaparin Sodium may interact with other anticoagulants, antiplatelet drugs, and nonsteroidal anti-inflammatory drugs (NSAIDs). Alcohol consumption should be avoided as it can increase the risk of bleeding. Patients should also be cautious when using medications that affect blood clotting.